Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases

Launched by GROUPE D'ETUDE THERAPEUTIQUE DES AFFECTIONS INFLAMMATOIRES DIGESTIVES · Dec 18, 2024

Keywords

ClinConnect Summary

The clinical trial titled "Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases" is looking at a new tool called MedicWise that helps monitor patients with Crohn's disease and ulcerative colitis. The main goal of the study is to see if using this remote monitoring device can help improve symptoms in patients who are currently experiencing active disease. The tool automatically collects health information, which means patients won’t need to provide as much input themselves. The study also aims to understand how this tool affects the care teams that look after patients with these conditions.

To participate in this trial, individuals must be at least 18 years old and have a diagnosed case of Crohn's disease or ulcerative colitis that is showing signs of increased activity, which means their treatment may need to be adjusted. Participants should also have a smartphone and be willing to use it for the study over a period of 52 weeks. However, those who have had certain types of recent surgery or are expecting surgery soon, as well as pregnant individuals, will not be eligible. This trial is currently not recruiting participants, but it aims to gather important information that could improve how patients with inflammatory bowel diseases are monitored and treated in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • CD/UC patients with a validated diagnosis
• • Patients age \> 18 years
• • IBD with clinical signs of PRO2 activity leading to modification of medical treatment: introduction of a new treatment, or change of dose or addition of a treatment (corticoids, ASA, IS, biotherapy)
• • Patients equipped with a smartphone and agreeing to use it for the purpose of the study.
• • Patients agreeing to participate for 52 weeks
• Exclusion Criteria:
• • Patients with an inability to use a smartphone and email
• • Patients \< 18 years old
• • Digestive surgery expected within 3 months
• • Pregnancy at baseline
• • Patients with an history of sub-total colectomy, coloproctectomy, digestive ostomy, extensive or multiple intestinal resections with sequelae of diarrhoea, short bowel syndrome.
• • Patients who have had recent digestive surgery (ileal resection \< 6 months)